Abbott-Exact Sciences deal to be reviewed by Australian antitrust regulator
MLex Summary: Global healthcare company Abbott Laboratories’ proposal to acquire Exact Sciences will be reviewed under the new mandatory merger regime, the Australian competition watchdog said Monday. In a statement, the...To view the full article, register now.
Already a subscriber? Click here to view full article